Investment Stage

Focus Areas

About Investor

HJ Hong is an Associate at Romulus Capital, where he focuses on investments in healthcare, pharma-tech, and construction tech. Romulus says it mainly leads Seed and Series A rounds for B2B companies selling technology into large traditional industries and deep technology companies spun out of top-tier research groups, and it leads rounds at the Seed, Series A, and Series B stages. The firm also states it writes checks anywhere from $250,000 to $10 million. Before Romulus, he worked on cancer immunotherapy and CRISPR-Cas9 research at Columbia University and earlier conducted research at Seoul National University of Science and Technology.